Skip to content
Research Article Open access CC BY 4.0

Phenotypic Detection of Extended Spectrum Beta-Lactamase and Carbapenemases Produced by Klebsiella spp Isolated from Three Referrals Hospitals in Yaounde, Cameroon

Anicette Chafa Betbeu, Hortense Gonsu Kamga, Michel Toukam, Calixte Didier Mbakop, Emilia Enjema Lyonga, Serge Bilong, Sinata Koulla- Shiro

Microbiology Research Journal International · pp. 1–9 · Published 9 Jun 2015

10.9734/BMRJ/2015/18250

Abstract

Aims: The main objective of this study was to determine the resistance phenotype of β-lactamines by Klebsiella in three hospitals in Yaoundé. Study Design: A cross-sectional descriptive study. Place and Duration of Study: Bacteriology laboratories of three referrals hospitals in Yaounde (University Teaching Hospital, General Hospital and Gynaeco-Obstetric and Pediatric Hospital) between May and November 2013. Methodology: A cross-sectional descriptive study was carried out over a 6 month-period from May to November 2013 in the bacteriology laboratories of three referrals hospitals in Yaounde. 99 strains ofKlebsiella spp. were collected for the study. Antimicrobial susceptibility testing was done using the disc diffusion method. The antibiotics tested were the β-lactams, other inhibitors like clavulanic acid, tazobactam, Ethylene-Diamine-Tetra-Acetic Acid (EDTA), cloxacillin and 3-aminophenyl boronic acid hydrochloride. The minimum inhibitory concentration (MIC) was also determined to enable the classification of the different resistance phenotypes. Results: Ninety-nine Klebsiella spp. were identified from urine (52.5%), blood (21.2%), pus (15.2%) and others sites (11.1%). The distribution of the Klebsiella spp. was: Klebsiella pneumoniae pneumoniae (78.7%), Klebsiella oxytoca (12.12%), Klebsiella pneumoniae ozaenae (5.05%), and Klebsiella pneumoniae rhinoscleromatis (4.04%). The isolates were most resistant to piperacillin (76%) and cephalothin, (85%). The most active antibiotics were imipenem (99%), and ertapenem (77%). The phenotypic tests revealed the following resistance phenotypes: extended-spectrum beta-lactamase (30.30%), wild (27.27%), penicillinase resistant to inhibitors (16.16%), carbapenemase (11.11%). Out of these 99 Klebsiella spp., 5 were carbapenemases producers of class C and 6 of class D. The MIC were variable with different antibiotics tested but the MIC of imipenem were always lower than 1 µg/ml. Conclusion: The interpretation of the antimicrobial susceptibility testing has enabled the establishment of a high prevalence of expanded spectrum β-lactamase and consequently leading to an increase in the presence of carbapenemase producing Klebsiella spp. This could lead to therapeutic failure in case of treatment with beta-lactamines antibiotics. Therefore this trend needs to be monitored.

Klebsiella spp resistance phenotypes ESBL carbapenemases

References (20)

  1. 1 The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria [DOI]
  2. 2 Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy [DOI]
  3. 3 Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome [DOI]
  4. 4 Diversity, Epidemiology, and Genetics of Class D β-Lactamases [DOI]
  5. 5 Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality [DOI]
  6. 6 Spread of OXA-48-Encoding Plasmid in Turkey and Beyond [DOI]
  7. 7 Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase [DOI]
  8. 8 The Relationship Between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I -Lactamase-Producing Organisms [DOI]
  9. 9 Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit [DOI]
  10. 10 Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates [DOI]
  11. 11 Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey [DOI]
  12. 12 Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon [DOI]
  13. 13 Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Yaounde, Cameroon [DOI]
  14. 14 Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. [DOI]
  15. 15 Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center [DOI]
  16. 16 Prevalence of β-Lactamases among 1,072 Clinical Strains of Proteus mirabilis : a 2-Year Survey in a French Hospital [DOI]
  17. 17 Les carbapénèmases des entérobactéries [DOI]
  18. 18 Antibiotic Resistance Rates and Phenotypes Among Isolates of Enterobacteriaceae in French Extra-Hospital Practice [DOI]
  19. 19 Résistance aux carbapénèmes : vers une nouvelle impasse ? [DOI]
  20. 20 Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins [DOI]

Cited by 17

Prevalence and Phenotypic and Molecular Characterization of Carbapenemase-Producing Gram-Negative Bacteria in Gabon

Annicet-Clotaire Dikoumba, R. Onanga, H. jean-Pierre · American Journal of Tropical Medicine and Hygiene · 2022

High Prevalence of Multidrug Resistant Klebsiella Species Isolated from the Yaounde University Teaching Hospital, Cameroon

E. L. Mbamyah, Florence Anjabie Enyeji, J. Torimiro · Open Journal of Medical Microbiology · 2021

Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps.

Elizabeth A. Mitgang, David M. Hartley, Marissa D. Malchione · International Journal of Antimicrobial Agents · 2018

Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa

Danielle M. Venne, David M. Hartley, Marissa D. Malchione · Antimicrobial Resistance & Infection Control · 2023

Showing 9 of 17 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

55

Page views

0

PDF downloads

36

Outbound clicks

17

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.